Maternal inflammation regulates fetal emergency myelopoiesis
Cell · 2024-03 · 187 (6) · 1402-1421.e21
DOI: 10.1016/j.cell.2024.02.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cell, 2024-03. Verfasst von Amélie Collins und 7 weiteren Autor:innen. Beteiligte Einrichtung: Columbia Stem Cell Initiative, Columbia University Irving Medical Center, New York, NY 10032, USA; Division of Neonatology-Perinatology, Department o…. Hauptthemen laut MEDLINE: Inflammation, Interleukin-10, Myelopoiesis. Die Arbeit wurde bisher 46-mal zitiert (Crossref) und nennt 96 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHLBI NIH HHS, NIDDK NIH HHS, NCI NIH HHS.
Abstract (Originalsprache)
Neonates are highly susceptible to inflammation and infection. Here, we investigate how late fetal liver (FL) mouse hematopoietic stem and progenitor cells (HSPCs) respond to inflammation, testing the hypothesis that deficits in the engagement of emergency myelopoiesis (EM) pathways limit neutrophil output and contribute to perinatal neutropenia. We show that fetal HSPCs have limited production of myeloid cells at steady state and fail to activate a classical adult-like EM transcriptional program. Moreover, we find that fetal HSPCs can respond to EM-inducing inflammatory stimuli in vitro but are restricted by maternal anti-inflammatory factors, primarily interleukin-10 (IL-10), from activating EM pathways in utero. Accordingly, we demonstrate that the loss of maternal IL-10 restores EM activation in fetal HSPCs but at the cost of fetal demise. These results reveal the evolutionary trade-off inherent in maternal anti-inflammatory responses that maintain pregnancy but render the fetus unresponsive to EM activation signals and susceptible to infection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Columbia Stem Cell Initiative, Columbia University Irving Medical Center, New York, NY 10032, USA; Division of Neonatology-Perinatology, Department of Pediatrics, Columbia University Irving Medical Center, New York, NY…
- Columbia Stem Cell Initiative, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY 10032, USA.
- Columbia Stem Cell Initiative, Columbia University Irving Medical Center, New York, NY 10032, USA; Division of Hematology/Oncology, Department of Internal Medicine, Columbia University Irving Medical Center, New York, N…
- Columbia Stem Cell Initiative, Columbia University Irving Medical Center, New York, NY 10032, USA; Department of Genetics and Development, Columbia University Irving Medical Center, New York, NY 10032, USA. Electronic a…
Förderung
- NHLBI NIH HHS
- NIDDK NIH HHS
- NCI NIH HHS
- NCATS NIH HHS
- EMBO
- Leukemia and Lymphoma Society
- Damon Runyon Cancer Research Foundation
- NIH
Zitieren
APA
Collins, A., Swann, J. W., Proven, M. A., Patel, C. M., Mitchell, C. A., Kasbekar, M., Dellorusso, P. V., & Passegué, E. (2024). Maternal inflammation regulates fetal emergency myelopoiesis. Cell, 187(6), 1402-1421.e21. https://doi.org/10.1016/j.cell.2024.02.002
Vancouver
Collins A, Swann JW, Proven MA, Patel CM, Mitchell CA, Kasbekar M, et al. Maternal inflammation regulates fetal emergency myelopoiesis. Cell. 2024;187(6):1402-1421.e21. doi:10.1016/j.cell.2024.02.002
BibTeX
@article{Collins2024,
author = {Collins, Amélie and Swann, James W and Proven, Melissa A and Patel, Chandani M and Mitchell, Carl A and Kasbekar, Monica and Dellorusso, Paul V and Passegué, Emmanuelle},
title = {Maternal inflammation regulates fetal emergency myelopoiesis},
journal = {Cell},
year = {2024},
volume = {187},
number = {6},
pages = {1402--1421.e21},
doi = {10.1016/j.cell.2024.02.002}
}
EUVIMED